Feb 26 (Reuters) - ⁠The ⁠U.S. CDC's ⁠vaccine advisory committee will ​discuss and may ‌vote on recommendations ‌for issues ...

Moderna will pay US$950-million upfront in July, 2026, with an additional US$1.3-billion contingent on the outcome of a separate legal appeal, while not owing royalties for the technology in its ...

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...

Researchers at University of California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, ...

In 2024, the U.S. Equal Employment Opportunity Commission (EEOC) sued Rex Healthcare on behalf of an employee fired for ...

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock added almost 9% after it was announced that the drugmaker has agreed to pay up to ...

Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

The Cambridge-based drug maker said the deal settles "all worldwide" litigation related to certain drugs and it won't have to pay royalties to other companies.

Moderna will pay $950 million upfront in July 2026, with an additional $1.3 billion contingent on the outcome of a separate ...

Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in ...